Andrea Vingiani

5.7k total citations
84 papers, 1.5k citations indexed

About

Andrea Vingiani is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Andrea Vingiani has authored 84 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Cancer Research, 48 papers in Oncology and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Andrea Vingiani's work include Cancer Genomics and Diagnostics (24 papers), Breast Cancer Treatment Studies (21 papers) and Cancer Cells and Metastasis (19 papers). Andrea Vingiani is often cited by papers focused on Cancer Genomics and Diagnostics (24 papers), Breast Cancer Treatment Studies (21 papers) and Cancer Cells and Metastasis (19 papers). Andrea Vingiani collaborates with scholars based in Italy, United States and United Kingdom. Andrea Vingiani's co-authors include Giancarlo Pruneri, Carsten Denkert, Giuseppe Viale, Giuseppe Curigliano, Patrick Maisonneuve, Vincenzo Bagnardi, Nicole Rotmensz, Carmen Criscitiello, Aron Goldhirsch and Claudio Vernieri and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Andrea Vingiani

73 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrea Vingiani Italy	21	857	642	345	276	265	84	1.5k
Marzia Locatelli Italy	17	757 0.9×	535 0.8×	329 1.0×	151 0.5×	221 0.8×	36	1.2k
Konstantinos Venetis Italy	22	746 0.9×	350 0.5×	316 0.9×	99 0.4×	295 1.1×	70	1.2k
Thomas B. Karasic United States	16	711 0.8×	282 0.4×	486 1.4×	111 0.4×	279 1.1×	65	1.3k
Anupma Nayak United States	20	462 0.5×	379 0.6×	416 1.2×	147 0.5×	226 0.9×	62	1.1k
Itzhak Avital United States	22	590 0.7×	453 0.7×	486 1.4×	114 0.4×	355 1.3×	42	1.5k
Naohiro Uraoka Japan	18	484 0.6×	330 0.5×	602 1.7×	149 0.5×	210 0.8×	48	1.1k
Jean‐Christophe Sabourin France	15	734 0.9×	243 0.4×	492 1.4×	230 0.8×	420 1.6×	29	1.4k
Elham Sajjadi Italy	20	654 0.8×	285 0.4×	262 0.8×	95 0.3×	240 0.9×	55	1.0k
Eliane C.M. Zeestraten Netherlands	19	709 0.8×	274 0.4×	466 1.4×	277 1.0×	189 0.7×	28	1.3k
Cheok Soon Lee Australia	24	459 0.5×	344 0.5×	738 2.1×	142 0.5×	341 1.3×	58	1.5k

Countries citing papers authored by Andrea Vingiani

Since Specialization

Citations

This map shows the geographic impact of Andrea Vingiani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Vingiani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Vingiani more than expected).

Fields of papers citing papers by Andrea Vingiani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Vingiani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Vingiani. The network helps show where Andrea Vingiani may publish in the future.

Co-authorship network of co-authors of Andrea Vingiani

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Vingiani. A scholar is included among the top collaborators of Andrea Vingiani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Vingiani. Andrea Vingiani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Santis, Francesca De, Silvia Brich, Andrea Vingiani, et al.. (2025). 43P Immunosuppressive microenvironment can be reverted by neoadjuvant chemotherapy in TNBC. ESMO Open. 10. 104202–104202.

Guerini‐Rocco, Elena, Simonetta Buglioni, Fabio Pagni, et al.. (2025). Part II – Analytical phase. Pathologica. 117(2). 18–18. 1 indexed citations

Appierto, Valentina, Elena Tamborini, Paola Tiberio, et al.. (2025). Circulating tumor DNA to anticipate loco-regional recurrence in early-stage breast cancer: a proof-of-concept study. Frontiers in Oncology. 15. 1621322–1621322.

Miglietta, Federica, Claudio Vernieri, Matilde Cacciatore, et al.. (2024). Prognosis and tumor-infiltrating lymphocytes (TILs) in estrogen receptor (ER)-low metastatic breast cancer (MBC): Analysis from a large multi-institutional cohort and the TONIC phase II trial with nivolumab.. Journal of Clinical Oncology. 42(16_suppl). 1100–1100.

Ciniselli, Chiara Maura, Paolo Verderio, Paolo Baili, et al.. (2024). Clinical and Biological Significance of HER2-Low in Ductal Carcinoma In Situ of the Breast. Clinical Breast Cancer. 25(1). e79–e85.e1. 1 indexed citations

Vernieri, Claudio, Francesca Ligorio, Claudia De Angelis, et al.. (2023). 352TiP Neoadjuvant chemo-immunotherapy plus/minus fasting-like approach in stage II-III triple-negative breast cancer patients: The phase II randomized BREAKFAST-2 trial. Annals of Oncology. 34. S322–S323. 2 indexed citations

Costa, Guido, Carlo Sposito, Cristiana Soldani, et al.. (2023). Macrophage morphology and distribution are strong predictors of prognosis in resected colorectal liver metastases: results from an external retrospective observational study. International Journal of Surgery. 109(5). 1311–1317. 5 indexed citations

Ferrando, Lorenzo, Andrea Vingiani, Anna Garuti, et al.. (2023). ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC). PLoS Genetics. 19(1). e1010563–e1010563. 7 indexed citations

Capone, Iolanda, Fabio Bozzi, Gian Paolo Dagrada, et al.. (2022). Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples. SHILAP Revista de lepidopterología. 3(5). 582–597. 3 indexed citations

10.

Ripamonti, Carla B., Paolo Bossi, Siranoush Manoukian, et al.. (2021). Malignant salivary gland tumours in families with breast cancer susceptibility. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 479(1). 221–226. 1 indexed citations

11.

Minna, Emanuela, Silvia Brich, Katia Todoerti, et al.. (2020). Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma. Cancers. 12(1). 112–112. 40 indexed citations

12.

Alfieri, Salvatore, Francesca Platini, Federica Perrone, et al.. (2020). Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma. Cancers. 12(4). 922–922. 12 indexed citations

13.

Lazzeroni, Matteo, Andrea DeCensi, Aliana Guerrieri‐Gonzaga, et al.. (2020). Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast. Modern Pathology. 33(6). 1065–1077. 5 indexed citations

14.

Criscitiello, Carmen, Andrea Vingiani, Patrick Maisonneuve, Giulia Viale, & Giuseppe Curigliano. (2020). Tumor-infiltrating lymphocytes (TILs) in ER+/HER2− breast cancer. Breast Cancer Research and Treatment. 183(2). 347–354. 74 indexed citations

15.

Salgado, Roberto, Maria Vittoria Dieci, Andrea Vingiani, et al.. (2018). Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy. Annals of Oncology. 30(2). 236–242. 119 indexed citations

16.

Montagna, Emilia, Andrea Vingiani, Patrick Maisonneuve, et al.. (2017). Unfavorable prognostic role of tumor-infiltrating lymphocytes in hormone-receptor positive, HER2 negative metastatic breast cancer treated with metronomic chemotherapy. The Breast. 34. 83–88. 22 indexed citations

17.

Criscitiello, Carmen, Vincenzo Bagnardi, Giancarlo Pruneri, et al.. (2017). Prognostic value of tumour-infiltrating lymphocytes in small HER2-positive breast cancer. European Journal of Cancer. 87. 164–171. 4 indexed citations

18.

Gobbo, Alessandro Del, et al.. (2016). Pulmonary squamous cell carcinoma with lepidic growth pattern: New insights into lung cancer classification. International Journal of Clinical and Experimental Pathology. 9(7). 7668–7673.

19.

DeCensi, Andrea, Matteo Puntoni, Aliana Guerrieri‐Gonzaga, et al.. (2015). Effect of Metformin on Breast Ductal Carcinoma In Situ Proliferation in a Randomized Presurgical Trial. Cancer Prevention Research. 8(10). 888–894. 27 indexed citations

20.

Vingiani, Andrea, Patrick Maisonneuve, Patrizia Dell’Orto, et al.. (2013). The clinical relevance of micropapillary carcinoma of the breast: a case–control study. Histopathology. 63(2). 217–224. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact